Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/1/09 20:06 | 6/29/09 | GENR | Health | BioPrd | Biological Products, (No Diag | Xmark Opportunity Partners, LLC | CT | T | S | -4 | 0.1015 | 0 | -43 | -1 | 2,796 | I | |||||||||||||||
6/9/09 20:37 | 6/5/09 | GENR | Health | BioPrd | Biological Products, (No Diag | Xmark Opportunity Partners, LLC | CT | T | S | -427 | 0.3095 | 0 | -1,379 | -33 | 2,838 | I | |||||||||||||||
8/22/06 08:56 | 8/21/06 | GENR | Health | BioPrd | Biological Products, (No Diag | Shapiro Robert F | PA | D | S | -10 | 0.5099 | 0 | -20 | -11 | 168 | D | |||||||||||||||
3/17/06 18:28 | 3/15/06 | GENR | Health | BioPrd | Biological Products, (No Diag | Levitt Roy C | PA | D | S | -133 | 1.33 | 0 | -100 | -57 | 75 | ||||||||||||||||
3/17/06 16:37 | 3/3/06 | GENR | Health | BioPrd | Biological Products, (No Diag | Levitt Roy C | PA | D | S.ad | -354 | 1.44 | 0 | -246 | -58 | 175 | ||||||||||||||||
3/13/06 18:03 | 3/6/06 | GENR | Health | BioPrd | Biological Products, (No Diag | Levitt Roy C | PA | D | S | -354 | 1.44 | 0 | -246 | -58 | 175 | ||||||||||||||||
9/5/03 20:18 | 9/3/03 | GENR | Health | BioPrd | Biological Products, (No Diag | Bvf Partners L P/il | IL | T | S.d | -2,694 | 4.81 | 0 | -560 | -22 | 1,939 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |